Canada’s Strategic Innovation Fund will provide $19.2m for accelerator Creative Destruction Lab over four years with the aim of supporting more than 1,300 science-focused companies.

The Rockefeller spinout will use the series C proceeds to advance two cancer drug candidates through early-stage clinical trials.

Oxford spinout Covatic has now raised $2.1m in funding for a software platform that enables media broadcasters to tailor mobile content and marketing to the habits of specific users.

Ben Soffer will stand down as managing director of Technion Technology Transfer after 13 years in charge.

Cornell spinout Gotham Therapeutics has come out of stealth with a series A round co-led by SR One, Versant Ventures and Forbion.

Glympse Bio, a medical diagnostic sensor spinout from MIT, has secured $22m in a series A round ahead of clinical trials targeting fatty liver disease and cancer.

The university’s Office of Technology Transfer launched 21 spinouts while achieving a 10% rise in inventions disclosed and a record number of licences and options agreed.

HUJ’s tech transfer arm still hopes to raise a further $3m for the fund to close it at $9m and has already invested in three technologies.

The Delft-affiliated fund has reached its first close on its way to a $120m target, having secured capital from a range of limited partners.

Johns Hopkins oncology diagnostics spinout PGDx had previously raised approximately $99m.